0001193125-17-331977.txt : 20171103 0001193125-17-331977.hdr.sgml : 20171103 20171103090102 ACCESSION NUMBER: 0001193125-17-331977 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20171103 DATE AS OF CHANGE: 20171103 EFFECTIVENESS DATE: 20171103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Natixis Funds Trust II CENTRAL INDEX KEY: 0000052136 IRS NUMBER: 041990692 STATE OF INCORPORATION: MA FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 002-11101 FILM NUMBER: 171174759 BUSINESS ADDRESS: STREET 1: 888 BOYLSTON STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 800-283-1155 MAIL ADDRESS: STREET 1: 888 BOYLSTON STREET STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 FORMER COMPANY: FORMER CONFORMED NAME: IXIS Advisor Funds Trust II DATE OF NAME CHANGE: 20050502 FORMER COMPANY: FORMER CONFORMED NAME: CDC NVEST FUNDS TRUST II DATE OF NAME CHANGE: 20010503 FORMER COMPANY: FORMER CONFORMED NAME: NVEST FUNDS TRUST II DATE OF NAME CHANGE: 20000202 0000052136 S000023548 ASG Global Alternatives Fund C000069269 Class A GAFAX C000069270 Class C GAFCX C000069271 Class Y GAFYX C000128763 Class N GAFNX C000188565 Class T GAFTX 0000052136 S000029564 ASG Managed Futures Strategy Fund C000090725 Class A AMFAX C000090726 Class C ASFCX C000090727 Class Y ASFYX C000188567 Class T MFSTX C000190721 Class N AMFNX 497 1 d482949d497.htm NATIXIS FUNDS TRUST II Natixis Funds Trust II

ASG GLOBAL ALTERNATIVES FUND

ASG MANAGED FUTURES STRATEGY FUND

Supplement dated November 3, 2017 to the Summary Prospectuses, Prospectus and Statement of Additional Information of the ASG Global Alternatives Fund and ASG Managed Futures Strategy Fund (each a “Fund” and, collectively, the “Funds”), each dated May 1, 2017, as may be revised and supplemented from time to time.

Effective January 1, 2018, Dr. Andrew Lo will no longer serve as a Co-Portfolio Manager of the Funds and he will transition to a new role at AlphaSimplex Group, LLC as Chairman Emeritus and Senior Advisor. Accordingly, effective January 1, 2018, all references to Dr. Lo and corresponding disclosure related to Dr. Lo in each Fund’s Summary Prospectus, Prospectus and Statement of Additional Information are hereby deleted.